Literature DB >> 9325162

Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon.

H Arimochi1, T Kinouchi, K Kataoka, T Kuwahara, Y Ohnishi.   

Abstract

The effect of intestinal bacteria on formation of azoxymethane (AOM)-induced aberrant crypt foci (ACF) and DNA adducts in the rat colon was investigated. Male Sprague-Dawley rats were administered cultures of Lactobacillus acidophilus, Bifidobacterium adolescentis, Bacteroides fragilis, Escherichia coli and Clostridium perfringens for five weeks and given injections of AOM at 15 mg/kg body weight at the first and second weeks. The number of ACF five weeks after the start of the experiment was decreased in the rats treated with the cultures or culture supernatants of L. acidophilus and C. perfringens. The half-life of O6-methylguanine (O6-meG) in the L. acidophilus group was shorter than that in the GAM broth group. The half-life of 7-methylguanine did not differ among the groups. These results suggest that the metabolite(s) of L. acidophilus and C. perfringens inhibit(s) the ACF formation in rats treated with AOM and that the inhibitory effect of L. acidophilus is due to the enhanced removal of O6-meG from the colon mucosal DNA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9325162     DOI: 10.1006/bbrc.1997.7384

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

2.  The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse.

Authors:  Carol J Díaz-Díaz; Sean M Ronnekleiv-Kelly; Manabu Nukaya; Peter G Geiger; Silvia Balbo; Romel Dator; Bryant W Megna; Patrick R Carney; Christopher A Bradfield; Gregory D Kennedy
Journal:  Ann Surg       Date:  2016-09       Impact factor: 12.969

3.  Microbial Metabolites as Molecular Mediators of Host-Microbe Symbiosis in Colorectal Cancer.

Authors:  N P Hyland; A Houston; J M Keane; S A Joyce; C G M Gahan
Journal:  Results Probl Cell Differ       Date:  2020

Review 4.  Intestinal microbiome and lymphoma development.

Authors:  Mitsuko L Yamamoto; Robert H Schiestl
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

5.  The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition.

Authors:  Elise L Ma; Yoon Jeong Choi; Jinyoung Choi; Charalabos Pothoulakis; Sang Hoon Rhee; Eunok Im
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

Review 6.  The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?

Authors:  M Andrea Azcárate-Peril; Michael Sikes; José M Bruno-Bárcena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-23       Impact factor: 4.052

Review 7.  Potential uses of probiotics in clinical practice.

Authors:  Gregor Reid; Jana Jass; M Tom Sebulsky; John K McCormick
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

Review 8.  Intestinal microbiota, probiotics and human gastrointestinal cancers.

Authors:  Antonella Orlando; Francesco Russo
Journal:  J Gastrointest Cancer       Date:  2013-06

Review 9.  Lymphoma caused by intestinal microbiota.

Authors:  Mitsuko L Yamamoto; Robert H Schiestl
Journal:  Int J Environ Res Public Health       Date:  2014-09-01       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.